Atlas Trials

A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible

Clinical trial NCT07070960 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07070960
Sponsor
Xuzhou Medical University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Multiple MyelomaNewly Diagnosed
Start date
2025-07-15
Primary completion
2026-07-15
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.